Table 2. .
HCV/DENV (n = 11) | HCV Control (n = 33) | P | |
---|---|---|---|
Age, y | 59.7 ± 14.2 | 60.2 ± 13.3 | .916 |
Male | 6 (54.5) | 18 (54.5) | 1.000 |
HCV genotype-1/2 | 7/4 | 22/11 | 1.000 |
HCV RNA follow-up interval, mo | 23.0 (21.1–33.0) | 26.5 (18.3–42.0) | .283 |
The changes of viral loads | |||
∆HCV RNA, log IU/mL | 2.34 ± 1.15 | –0.27 ± 0.76 | <.001 |
∆HCV RNA >0.5 log | 11 (100.0) | 2 (6.06) | <.001 |
│∆HCV RNA│<0.5 log | 0 (0.00) | 24 (72.7) | <.001 |
│∆HCV RNA│<1 log | 2 (18.2) | 28 (84.8) | <.001 |
Data are presented as No. (%), mean ± SD, or median (interquartile range). HCV RNA levels are presented as logarithmic values (base number 10). ∆HCV RNA was calculated by the individual difference of HCV RNA levels during the DF episode and the follow-up stage in the HCV/DENV dual-infected group or the individual difference of HCV RNA level between similar periods in HCV controls; │∆HCV RNA│ denotes the absolute value of ∆HCV RNA. HCV RNA follow-up interval is expressed as median (interquartile range).
Abbreviations: DENV, dengue virus; HCV, hepatitis C virus.